Schienle Anne, Seibel Arved
Department of Clinical Psychology, University of Graz, Graz, Austria.
Psychol Res Behav Manag. 2024 Feb 2;17:393-400. doi: 10.2147/PRBM.S439783. eCollection 2024.
Open-label placebos (OLPs), honestly prescribed regarding their inert nature, have been associated with positive health-related effects in both children and adults. However, OLPs are not always perceived by laypeople as a viable treatment option.
A brief online survey with 806 adult participants (age range: 18-75 years; 29% parents) was conducted to identify predictor variables that are associated with the willingness to take an OLP pill (criterion 1) or to give an OLP to one's child (criterion 2). The survey covered aspects including the perceived plausibility of the treatment concept for both OLPs and deceptive placebos (DPs), self-reported knowledge about placebos, the expected effectiveness of OLPs in treating emotional/ somatic problems, and attitudes concerning taking pills in general. Multiple hierarchical regressions were carried out.
The expected effectiveness of OLPs in alleviating both emotional and physical ailments and the plausibility of the treatment concepts for both OLPs and DPs significantly predicted the willingness to use OLPs (R = 0.485). A similar finding was observed when predicting the willingness to administer an OLP to one's child (R = 0.443).
Favorable expectations regarding the reduction of emotional and somatic symptoms with OLPs, along with a strong belief in the credibility of placebo mechanisms, play a vital role in influencing the willingness to accept this kind of treatment. These factors can be incorporated into psychoeducational programs.
开放标签安慰剂(OLP),在如实告知其惰性本质的情况下开出,已被证明在儿童和成人中都与积极的健康相关效果有关。然而,普通大众并不总是将OLP视为一种可行的治疗选择。
对806名成年参与者(年龄范围:18 - 75岁;29%为家长)进行了一项简短的在线调查,以确定与愿意服用OLP药丸(标准1)或给孩子服用OLP(标准2)相关的预测变量。该调查涵盖了多个方面,包括对OLP和欺骗性安慰剂(DP)治疗概念的感知合理性、自我报告的安慰剂知识、OLP在治疗情绪/身体问题方面的预期效果以及对一般服药的态度。进行了多重层次回归分析。
OLP在缓解情绪和身体疾病方面的预期效果以及OLP和DP治疗概念的合理性显著预测了使用OLP的意愿(R = 0.485)。在预测给孩子服用OLP的意愿时也观察到了类似的结果(R = 0.443)。
对OLP减轻情绪和身体症状的良好期望,以及对安慰剂机制可信度的坚定信念,在影响接受这种治疗的意愿方面起着至关重要的作用。这些因素可以纳入心理教育项目中。